<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02384551</url>
  </required_header>
  <id_info>
    <org_study_id>CLNB-006-14S</org_study_id>
    <nct_id>NCT02384551</nct_id>
  </id_info>
  <brief_title>Dietary Carbohydrate and GERD in Veterans</brief_title>
  <acronym>DietGERD</acronym>
  <official_title>Dietary Carbohydrate Effects on GERD in Obese Veterans: Nutritional or Hormonal?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      4-Arm Diet Intervention Investigating Effects of Dietary Carbohydrate Type and Amount on
      gastroesophageal pH, gastroesophageal reflux disease (GERD) symptoms and medication use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Hypothesis: The preliminary findings suggest a physiological mechanism between
      dietary intake and GERD that may be related to type of dietary carbohydrate intake (complex
      vs simple carbohydrate). The investigators hypothesize that modifying the type of dietary
      carbohydrate consumed - by reducing the proportion of simple carbohydrate (sugars) consumed -
      will reduce or resolve GERD symptoms and medication use in obese Veterans with chronic GERD.
      The investigators further hypothesize that the mechanistic effects of reducing simple
      carbohydrate intake is related to either: a) improved dietary fiber intake and/or glycemic
      load, and thus, reduced amount and duration of esophageal acid exposure; and/or b) improved
      insulin sensitivity which would positively influence the function of key gastrointestinal
      hormones (ie, gastrin, glucagon, GLP-1, ghrelin11) that regulate gastric motility and/or
      lower esophageal sphincter function.

      Aim 1: To determine effects of dietary carbohydrate consumed (amount and type) on percent
      time with esophageal pH &lt; 4.0, as well as number of reflux episodes, GERD symptoms and GERD
      medication use, in 200 obese Veterans who have chronic high frequency of GERD symptoms. To
      meet this aim the investigators will use a randomized controlled trial in which the
      investigators manipulate amount of total and simple dietary carbohydrate intake for duration
      of 9 weeks.

      Aim 2: To assess associations between GERD resolution variables and factors related to
      potential mechanisms by which modifying dietary carbohydrate intake could resolve/reduce GERD
      in obese Veterans.

      2a: The investigators will investigate associations related to whether the effect is
      nutritionally mediated by measuring change in dietary fiber load and dietary glycemic load,
      and thus, whether these changes are related to improved gastric acid secretion (% time pH &lt;
      4), gastric motility, and/or the other parameters that comprise the Johnson-DeMeester score.

      2b: The investigators will also investigate whether effects are associated with changes in
      the hormonal milieu by measuring hormonal response of gastrin, glucagon, glucagon-like
      peptide-1 (GLP-1), ghrelin and insulin, which could potentially influence gastric acid
      secretion, gastric motility and/or lower esophageal sphincter function.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastroesophageal pH</measure>
    <time_frame>24 hours</time_frame>
    <description>ambulatory ph monitoring for gastroesophageal ph, number and frequency of reflux episodes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>GERD symptoms</measure>
    <time_frame>9 weeks</time_frame>
    <description>GERD symptoms measured weekly for 9 weeks using Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GERD medication use</measure>
    <time_frame>9 weeks</time_frame>
    <description>Weekly measure of type, amount and dose of GERD medication use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GERD symptoms</measure>
    <time_frame>9 weeks</time_frame>
    <description>GERD symptoms measured weekly for 9 weeks using Gastroesophageal Reflux Disease Questionnaire (GERDQ)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Gastric hormones</measure>
    <time_frame>24 hour period</time_frame>
    <description>Plasma/serum measure of glucose, insulin, gastrin, glucagon, active ghrelin and active GLP-1</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>HTHS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High total carbohydrate with high total simple carbohydrate diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HTLS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High total carbohydrate with low total simple carbohydrate diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LTHS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low total carbohydrate with low total simple carbohydrate diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LTLS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low total carbohydrate with low total simple carbohydrate diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Carbohydrate</intervention_name>
    <description>9 week menu of dietary carbohydrate modification</description>
    <arm_group_label>HTHS</arm_group_label>
    <arm_group_label>HTLS</arm_group_label>
    <arm_group_label>LTHS</arm_group_label>
    <arm_group_label>LTLS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age 21 or over BMI 30-39.9 GERD

        Exclusion Criteria:

          -  History of type 1 diabetes

          -  Hernia or strictures

          -  Gastroparesis

          -  Extra-esophageal GERD

          -  Barrett's esophagus or Esophageal adenocarcinoma

          -  History of gastric or bariatric or esophageal surgery, radiation or cancer

          -  History of gastrointestinal malabsorption

          -  Alcohol averaging &gt; 2 drinks per day during past 3 months

          -  Pregnancy / Lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin D Niswender, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tennessee Valley Healthcare System Nashville Campus, Nashville, TN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heidi J Silver, PhD</last_name>
    <phone>(615) 593-1299</phone>
    <email>heidi.j.silver@vanderbilt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kevin D Niswender, MD PhD</last_name>
    <phone>(615) 936-0500</phone>
    <email>Kevin.Niswender@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tennessee Valley Healthcare System Nashville Campus, Nashville, TN</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212-2637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin D Niswender, MD PhD</last_name>
      <phone>615-936-0500</phone>
      <email>Kevin.Niswender@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Heidi J Silver, PhD</last_name>
      <phone>(615) 593-1299</phone>
      <email>heidi.j.silver@vanderbilt.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kevin D Niswender, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2015</study_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GERD</keyword>
  <keyword>diet</keyword>
  <keyword>carbohydrate</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

